Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system
Joanne Y.T. Leung, Alasdair M. Barr, Ric M. Procyshyn, et al.
Pharmacology & Therapeutics (2012) Vol. 135, Iss. 2, pp. 113-122
Closed Access | Times Cited: 148

Showing 26-50 of 148 citing articles:

Autogenic Training in Mental Disorders: What Can We Expect?
Dagmar Breznoščáková, Milana Kovaničová, Eva Sedláková, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 4344-4344
Open Access | Times Cited: 11
Impact of cariprazine on body weight and blood pressure among adults with bipolar I disorder, schizophrenia, or major depressive disorder in a real-world setting
Christoph U. Correll, Andrew J. Cutler, François Laliberté, et al.
Annals of General Psychiatry (2025) Vol. 24, Iss. 1
Open Access
A Review of Clinical Advances and Challenges in Clozapine-Induced Myocarditis
Mier Li, Yunkai Bai, Yanjun Wang, et al.
Neuropsychiatric Disease and Treatment (2025) Vol. Volume 21, pp. 525-538
Open Access
Management of Parkinson’s disease psychosis: first-line antipsychotic selection and rationale for continuing, combining, or switching
Stuart Isaacson, Henry A. Nasrallah, Rajesh Pahwa, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Cardiovascular Changes due to Antipsychotic Agents among First Episode Patients with Schizophrenia
TO Iyidobi, TC Iyidobi, AC Ndukuba, et al.
Nigerian Journal of Clinical Practice (2025) Vol. 28, Iss. 3, pp. 280-286
Closed Access
Genetics of antipsychotic-induced weight gain: update and current perspectives
Amy CC Kao, Daniel J. Müller
Pharmacogenomics (2013) Vol. 14, Iss. 16, pp. 2067-2083
Closed Access | Times Cited: 41
Treatment of clozapine-associated weight gain: a systematic review
Zachary Whitney, Ric M. Procyshyn, Diane Fredrikson, et al.
European Journal of Clinical Pharmacology (2015) Vol. 71, Iss. 4, pp. 389-401
Closed Access | Times Cited: 40
Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine
Heidi N. Boyda, Ric M. Procyshyn, Catherine C.Y. Pang, et al.
PLoS ONE (2013) Vol. 8, Iss. 1, pp. e53459-e53459
Open Access | Times Cited: 39
Management of serious cardiac adverse effects of antipsychotic medications
Steven C. Stoner
Mental Health Clinician (2017) Vol. 7, Iss. 6, pp. 246-254
Open Access | Times Cited: 35
Drug repurposing and emerging adjunctive treatments for schizophrenia
Jan Malte Bumb, Frank Enning, F. Markus Leweke
Expert Opinion on Pharmacotherapy (2015) Vol. 16, Iss. 7, pp. 1049-1067
Closed Access | Times Cited: 32
Directions for Future Patient-Centered and Comparative Effectiveness Research for People With Serious Mental Illness

Schizophrenia Bulletin (2014) Vol. 40, Iss. Suppl_1, pp. i-S94
Open Access | Times Cited: 32
Tolerability of cariprazine in the treatment of acute bipolar I mania: A pooled post hoc analysis of 3 phase II/III studies
Willie Earley, Suresh Durgam, Kaifeng Lu, et al.
Journal of Affective Disorders (2017) Vol. 215, pp. 205-212
Open Access | Times Cited: 31
Clozapine-induced cardiotoxicity in rats: Involvement of tumour necrosis factor alpha, NF-κβ and caspase-3
Basel A. Abdel‐Wahab, Metwally E. Metwally
Toxicology Reports (2014) Vol. 1, pp. 1213-1223
Open Access | Times Cited: 29
Effects of chronic exercise and treatment with the antipsychotic drug olanzapine on hippocampal volume in adult female rats
Alasdair M. Barr, Che Hsuan David Wu, Ching Wong, et al.
Neuroscience (2013) Vol. 255, pp. 147-157
Closed Access | Times Cited: 28
Therapeutic Drug Levels of Second Generation Antipsychotics in Youth: A Systematic Review
Zachary Whitney, Heidi N. Boyda, Ric M. Procyshyn, et al.
Journal of Child and Adolescent Psychopharmacology (2015) Vol. 25, Iss. 3, pp. 234-245
Closed Access | Times Cited: 28
Ivabradine, a novel treatment for clozapine-induced sinus tachycardia: a case series
John Lally, Jennifer Brook, Thomas M. Dixon, et al.
Therapeutic Advances in Psychopharmacology (2013) Vol. 4, Iss. 3, pp. 117-122
Open Access | Times Cited: 27
Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale
Theodora A. Manolis, Antonis A. Manolis, Antonis S. Manolis
Angiology (2018) Vol. 70, Iss. 2, pp. 103-129
Closed Access | Times Cited: 25
Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice
Megan Beauchemin, Ramaz Geguchadze, Anyonya R. Guntur, et al.
Pharmacological Research (2019) Vol. 152, pp. 104589-104589
Open Access | Times Cited: 24
Antipsychotic Drugs and Risk of Hip Fracture in People Aged 60 and Older in Norway
Marit Stordal Bakken, Jan Schjøtt, Anders Engeland, et al.
Journal of the American Geriatrics Society (2016) Vol. 64, Iss. 6, pp. 1203-1209
Closed Access | Times Cited: 23
Recent Advances in representative small-molecule DRD2 inhibitors: Synthetic Routes and clinical applications
Yao Zhang, Jiangang Yu, Wen Wen
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116731-116731
Closed Access | Times Cited: 2
Hemodynamic response function abnormalities in schizophrenia during a multisensory detection task
Faith M. Hanlon, Nicholas A. Shaff, Andrew B. Dodd, et al.
Human Brain Mapping (2015) Vol. 37, Iss. 2, pp. 745-755
Open Access | Times Cited: 24
Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice
Bahman Rostama, Megan Beauchemin, Celeste Bouchard, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9362-9362
Open Access | Times Cited: 20
The Effect of a Biofeedback-Based Integrated Program on Improving Orthostatic Hypotension in Community-Dwelling Older Adults
Jeonghwa Han, Jooyeon Park, Hyun-Wook Kang, et al.
The Journal of Cardiovascular Nursing (2023)
Open Access | Times Cited: 6
Disability and Adverse Effects of Oral Versus Long-Acting Injectable Antipsychotics in Schizophrenia-Spectrum and Bipolar Disorder: A Comparison Based on Data-Driven Taxonomy
Alessandro Rodolico, Sofia Francesca Aprile, Pierfelice Cutrufelli, et al.
Clinical Drug Investigation (2024) Vol. 44, Iss. 9, pp. 715-727
Open Access | Times Cited: 2
Age-related variations in heart rate variability profiles among patients with schizophrenia and major depressive disorder
YuQing Gao, Linlin Zhou, Haisu Wu, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access | Times Cited: 2

Scroll to top